Prevalence of Vitamin D Deficiency and Associated Risk Factors in Cerebral Palsy,

Vahideh Toopchizadeh--- Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Sciences, Tabriz, Iran,
Mohammad Barzegar--- Pediatric Health Research Center, Tabriz University of Medical Scenes, Tabriz, Iran,
Shahab Masoumi--- School of Medicine, Tabriz University of Medical Scenes, Tabriz, Iran;,
Fatemeh Jahanjoo--- Department of Epidemiology & Biostatistics, School of public Health, Tehran University of Medical Sciences, Tehran, Iran



Objective: To compare prevalence of 25-hydroxyvitamin D deficiency in cerebral palsied (CP) with healthy control children and to evaluate possible correlations between 25-hydroxyvitamin D and severity of CP and motor function.

Materials & Methods: In this case control study, serum levels of 25-hydroxyvitamin D were evaluated in 65 children with CP and compared with 65 healthy children. Blood samples were taken to measure levels of 25-hydroxyvitamin D, calcium, phosphorus and alkaline phosphatase. Regarding 25-hydroxyvitamin D levels, patients were classified as sufficient (≥30 ng/ml), insufficient (20-30 ng/ml) and deficient (<20 ng/ml).

Results: Mean 25-hydroxyvitamin D levels were 28.03±24.2 ng/ml in patients and 30±1.94 ng/ml in control group. 25-hydroxyvitamin D deficiency was seen in 44.6% of CP and 18.5% of healthy children. There was no significant difference in 25-hydroxyvitamin D levels between boys and girls, CP types and use of antiepileptics in case group. There was significant negative correlation between age and 25-hydroxyvitamin D levels. The correlation between 25-hydroxyvitamin D and Gross Motor Function Classification System was not significant.   

Conclusion: 25-hydroxyvitamin D deficiency is common in children with CP in comparison with healthy children. There was significant negative correlation between age and 25-hydroxyvitamin D levels .Routine measurement of 25-hydroxyvitamin D levels and its proper treatment is recommended to prevent its deficiency and subsequent consequences.


Cerebral Palsy; Children; 25-hydroxyvitamin D; Motor function

Full Text:




Bax M, Goldstein M, Rosenbaum PL, Leviton A, Paneth N, Dan B, et al. Executive Committee for the Definition of Cerebral Palsy. Proposed definition and classification of cerebral palsy. Dev Med Child Neurol 2005; 47: 571-6.

Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl 2007; 109: 8–14.

Berker N, Yalçın S. The HELP guide to Cerebral Palsy. 2nd ed. Was¬hington, USA: Global Help-Merrill Corporation; 2010.p.7-131.

Brehaut JC, Kohen DE, Raina P, Walter SD, Russell DJ, Swinton M, et al. The health of primary caregivers of children with cerebral palsy: how does it compare with that of other Canadian caregivers? Pediatrics 2004; 114: e182-91.

Odding E, Roebroeck ME, Stam HJ. The epidemiology of cerebral palsy: incidence, impairments and risk factors. Disabil Rehabil 2006; 28: 183-91.

Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010; 106: 963–8.

Thomas MK, Demay MB. Vitamin D deficiency and disorders of vitamin D metabolism. Endocrinol Metab Clin North Am 2000; 29: 611-27.

Paksu MS, Vurucu S, Karaoglu A, Karacalioglu AO, Polat A, Yesilyurt O, et al. Osteopenia in children with cerebral palsy can be treated with oral alendronate. Childs Nerv Syst 2012; 28: 283-6.

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911–30.

Russell DJ, Avery LM, Rosenbaum PL, Raina PS, Walter SD, Palisano RJ. Improved scaling of the gross motor function measure for children with cerebral palsy: evidence of reliability and validity. Phys ther 2000; 80: 873-85.

Basu S, Gupta R, Mitra M, Ghosh A. Prevalence of vitamin d deficiency in a pediatric hospital of eastern India. Indian J Clin Biochem 2015; 30: 167-73.

Andıran N, Çelik N, Akça H, Doğan G. Vitamin D deficiency in children and adolescents. J Clin Res Pediatr Endocrinol 2012; 4: 25-9.

Saki F, Dabbaghmanesh MH, Omrani GR, Bakhshayeshkaram M. Vitamin D deficiency and its associated risk factors in children and adolescents in southern Iran. Public Health Nutr 2015 Jun 8:1-6. [Epub ahead of print]

Neyestani TR, Hajifaraji M, Omidvar N, Eshraghian MR, Shariatzadeh N, Kalayi A, et al. High prevalence of vitamin D deficiency in school-age children in Tehran, 2008: a red alert. Public Health Nutr 2012; 15: 324-30.

Lloyd ME, Spector TD, Howard R. Osteoporosis in neurological disorders. J Neurol Neurosurg Psychiatr 2000; 68: 543–7.

Fong CY, Riney CJ. Vitamin D deficiency among children with epilepsy in South Queensland. J Child Neurol 2014; 29: 368–73.

Wirrell E. Vitamin D and bone health in children with epilepsy: fad or fact? Pediatr Neurol 2010; 42: 394–5.

Mansbach JM, Ginde AA, Camargo CA Jr. Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: do children need more vitamin D? Pediatrics 2009; 124: 1404-10.

Choi HS, Oh HJ, Choi H, Choi WH, Kim JG, Kim KM, et al. Vitamin D insufficiency in Korea: a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab 2011; 96: 643-51.

Peterson MD, Haapala HJ, Chaddha A, Hurvitz EA. Abdominal obesity is an independent predictor of serum 25-hydroxyvitamin D deficiency in adults with cerebral palsy. Nutr Metab (Lond) 2014; 11: 22.

Al WT, Lee DC, Kay RM, Dorey FJ, Gilsanz V. Bone density and size in ambulatory children with cerebral palsy. Dev Med Child Neurol 2011; 53: 137-41.



  • There are currently no refbacks.

Copyright (c) 2018 Iranian Journal of Child Neurology